GPT and intrahepatic cholestasis: Moreover, the 12 g/kg and 24 g/kg DCHD treatment could decrease ALT, AST, ALP, γ-GT, TC, TBA, and TBIL levels in the ANIT-induced intrahepatic cholestasis model; the 24 g/kg DCHD-treated group produced a greater lessened effect on ALT and ALP levels than the UDCA-treated group (Figure 1C).